RARECast
A podcast by RARECast - Thursdays
548 Episodes
-
Leveraging Technology to Empower Patients and Decentralize Clinical Trials
Published: 10/20/2022 -
Equipping The Next-Generation Rare Disease Patient Advocate
Published: 10/13/2022 -
How a Family Raced from Diagnosis to Experimental Gene Therapy in Three Years
Published: 10/6/2022 -
How One Advocate Went from Losing His Hearing to Being Heard
Published: 9/29/2022 -
Building a Pipeline of Therapies to Treat Rare Mineralization Disorders
Published: 9/22/2022 -
Advancing an Oral Alternative to Infused and Injected Therapies for HAE
Published: 9/15/2022 -
Embracing the Promise of Patient-Centered Biotechnology
Published: 9/8/2022 -
Learning to Live with Loss
Published: 9/1/2022 -
Using Cryptocurrency to Tap into the Wisdom of Crowds
Published: 8/25/2022 -
A Therapy for a Rare Neurodegenerative Disease Moves Towards Regulatory Review
Published: 8/18/2022 -
Transforming the Treatment of Neuromuscular Diseases with Next-Gen Oligonucleotides
Published: 8/11/2022 -
Teaching the Immune System to Let Medicines Do Their Job
Published: 8/4/2022 -
Designing Clinical Trials with the Patient in Mind
Published: 7/28/2022 -
Keeping Clinical Trials Running Smoothly
Published: 7/21/2022 -
A Vision for Patient-Centric Gene Therapy Development
Published: 7/14/2022 -
Using Genetic Testing to Address Disparities in Care for Kidney Disease
Published: 7/7/2022 -
Why Reforms to the Accelerated Approval Pathway Threaten Rare Disease Drug Development
Published: 6/30/2022 -
A Longstanding Academic-Nonprofit Collaboration Gives Rise to an ALS Drug Company
Published: 6/16/2022 -
Targeting Regulatory RNA to Upregulate Gene Expression to Treat Rare Diseases
Published: 6/9/2022 -
Developing a New Approach to Treat Rare, Autoimmune Conditions
Published: 6/2/2022
RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.